MET Strangle Strategy
MET (MetLife, Inc.), in the Financial Services sector, (Insurance - Life industry), listed on NYSE.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
MET (MetLife, Inc.) trades in the Financial Services sector, specifically Insurance - Life, with a market capitalization of approximately $50.24B, a trailing P/E of 14.07, a beta of 0.78 versus the broader market, a 52-week range of 67.33-83.85, average daily share volume of 3.7M, a public-listing history dating back to 2000, approximately 45K full-time employees. These structural characteristics shape how MET stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.78 places MET roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. MET pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on MET?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current MET snapshot
As of May 15, 2026, spot at $79.65, ATM IV 24.70%, IV rank 28.35%, expected move 7.08%. The strangle on MET below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on MET specifically: MET IV at 24.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a MET strangle, with a market-implied 1-standard-deviation move of approximately 7.08% (roughly $5.64 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MET expiries trade a higher absolute premium for lower per-day decay. Position sizing on MET should anchor to the underlying notional of $79.65 per share and to the trader's directional view on MET stock.
MET strangle setup
The MET strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MET near $79.65, the first option leg uses a $82.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MET chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MET shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $82.50 | $1.18 |
| Buy 1 | Put | $75.00 | $0.93 |
MET strangle risk and reward
- Net Premium / Debit
- -$210.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$210.00
- Breakeven(s)
- $72.90, $84.60
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MET strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MET. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$7,289.00 |
| $17.62 | -77.9% | +$5,528.01 |
| $35.23 | -55.8% | +$3,767.01 |
| $52.84 | -33.7% | +$2,006.02 |
| $70.45 | -11.6% | +$245.02 |
| $88.06 | +10.6% | +$345.97 |
| $105.67 | +32.7% | +$2,106.97 |
| $123.28 | +54.8% | +$3,867.96 |
| $140.89 | +76.9% | +$5,628.96 |
| $158.50 | +99.0% | +$7,389.95 |
When traders use strangle on MET
Strangles on MET are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MET chain.
MET thesis for this strangle
The market-implied 1-standard-deviation range for MET extends from approximately $74.01 on the downside to $85.29 on the upside. A MET long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MET IV rank near 28.35% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MET at 24.70%. As a Financial Services name, MET options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MET-specific events.
MET strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MET positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MET alongside the broader basket even when MET-specific fundamentals are unchanged. Always rebuild the position from current MET chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MET?
- A strangle on MET is the strangle strategy applied to MET (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MET stock trading near $79.65, the strikes shown on this page are snapped to the nearest listed MET chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MET strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MET strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$210.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MET strangle?
- The breakeven for the MET strangle priced on this page is roughly $72.90 and $84.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MET market-implied 1-standard-deviation expected move is approximately 7.08%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MET?
- Strangles on MET are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MET chain.
- How does current MET implied volatility affect this strangle?
- MET ATM IV is at 24.70% with IV rank near 28.35%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.